Abstract: The present invention describes novel Cashew Nut Shell Liquid derived cycloaliphatic functional compounds and methods for making the same. The invention also provide methods to use these derivatives in antimicrobials, antioxidants, adhesives, coatings, corrosion retardants composites, cosmetics, detergents, soaps, de-icing products, elastomers, food, flavors, inks, lubricants, oil field chemicals, tackifiers, prepolymer chain-extenders, rheology modifiers, electrical and electronic components (potting, castings, encapsulants), personal care products, polymers, structural polymers, engineered plastics, 3D printable polymers, 3D printable polymers, UV/E-beam/cationic curable polymers, techno-polymers, rubbers, sealants, solvents, surfactants and varnishes, transformer oil, lubricants.

Abstract: The present invention is directed to Cashew Nut Shell Liquid derivatives and methods for making and using same. The invention is also directed to Cashew Nut Shell Liquid based monomers and polymers for making antimicrobials, antioxidants, adhesives, coatings, corrosion retardants composites, cosmetics, detergents, soaps, de-icing products, elastomers, food, flavors, inks, lubricants, oil field chemicals, personal care products, polymers, structural polymers, engineered plastics, 3D printable polymers, techno-polymers, rubbers, sealants, solvents, surfactants and varnishes.

Abstract: Embodiments provided herein, relate to, in part, oxidative degradation of Cashew Nut Shell Liquid (CNSL) derivatives methods for making the same, and uses thereof, including embodiments relating to coatings, varnishes, adhesives compositions, polyurethane systems, thermoplastic and thermoset polymers and the like.

Abstract: The present disclosure provides cashew nut shell liquid derivatives based organosilicon products and methods and uses of preparing the same.

Abstract: Embodiments provided herein, relate to, in part, oxidative degradation of Cashew Nut Shell Liquid (CNSL) derivatives methods for making the same, and uses thereof, including embodiments relating to coatings, varnishes, adhesives compositions, polyurethane systems, thermoplastic and thermoset polymers and the like.

Abstract: The present disclosure provides cashew nut shell liquid derivatives based organosilicon products and methods and uses of preparing the same.

Abstract: Cardanol derivative comprising one or more units of the formula and a method for obtaining such cardanol derivative.

Abstract: New peptidomimetic inhibitors of retroviral proteases are in particular for human immunodeficiency virus (HIV) protease. These inhibitors include as the core structure a new diamiriodiol isostere of the dipeptide Phe-Pro having four stereogenic centers. The inhibitors have been shown to inhibit HIV-protease and can therefore be usefully employed as antivirals for post-exposure prophylaxis and as a therapy for viral infections by a retrovirus, in particular HIV. The syntheses processes of the isosteres and inhibitors are also described.

Abstract: The patent describes homo- or hetero-bifunctional derivatives of polyethylene glycol (PEG) obtained by selectively modifying the hydroxyl end groups of commercial PEGs of different molecular weights with reactive bifunctional molecules. The synthesis process comprises steps involving sequential derivatization of PEG terminal hydroxyl groups with a bifunctional compound, purification of the bifunctional PEG obtained and/or protection of its functional groups with possible selective removal of terminal protections. The bifunctional PEGs (biPEG) obtained are usable as carriers and/or stabilizers for substances used for diagnostic, prophylactic and therapeutic purposes, conjugated to the same biocompatible biPEG support. The bifunctionalized PEG derivatives can also be used in supported synthesis processes.

Abstract: The patent describes new peptidomimetic inhibitors of retroviral proteases, in particular of human immunodeficiency virus (HIV) protease. These inhibitors comprise as the core structure a new diaminodiol isostere of the dipeptide Phe-Pro having four stereogenic centres. The inhibitors of the invention have been shown to inhibit HIV protease and can therefore be usefully employed as antivirals for post-exposure prophylaxis and as a therapy for viral infections by a retrovirus, in particular HIV. The syntheses processes of the isosteres and inhibitors are also described.